Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00382785 | Psychosocial Outcomes in Online Cancer Support Groups | completed | N/A | 51 | Christiana Care Health ServicesOTHER | 1 | Dec 21, 2010 | clinicaltrials |
| NCT00647075 | Yunzhi as Dietary Supplement in Breast Cancer(YUNZHI-BC) | unknown | Phase 4 | 60 | Hospital Clinic of BarcelonaOTHER | 1 | Dec 15, 2010 | clinicaltrials |
| NCT00078572 |
| Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer |
| completed |
| Phase 3 |
| 408 |
| GlaxoSmithKlineINDUSTRY |
| 0 |
| Dec 13, 2010 |
| clinicaltrials |
| NCT00727883 | Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients(SOSTA) | completed | — | 190 | AstraZenecaINDUSTRY | 0 | Dec 10, 2010 | clinicaltrials |
| NCT00888082 | Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy(PROOF) | withdrawn | Phase 3 | 102 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT01108016 | Expanding Rural Access: Distance Delivery of Support Groups (Main Study) | completed | Phase 3 | 100 | Stanford UniversityOTHER | 1 | Dec 6, 2010 | clinicaltrials |
| NCT00897728 | Study of Tumor and Blood Samples From Women With Breast Cancer | unknown | — | 180 | Institut CurieOTHER | 1 | Dec 1, 2010 | clinicaltrials |
| NCT00328120 | Faslodex 500mg Multiple Dose Tolerability Study in BC Patients | completed | Phase 1 | 20 | AstraZenecaINDUSTRY | 1 | Nov 17, 2010 | clinicaltrials |
| NCT00398489 | Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | unknown | Phase 2 | 94 | Technical University of MunichOTHER | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00897416 | Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer | completed | — | 1,452 | Fred Hutchinson Cancer CenterOTHER | 0 | Nov 9, 2010 | clinicaltrials |
| NCT00994968 | Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer | unknown | Phase 2 | 49 | Yonsei UniversityOTHER | 1 | Oct 29, 2010 | clinicaltrials |
| NCT00480597 | Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer | completed | Phase 2 | 141 | Ludwig-Maximilians - University of MunichOTHER | 0 | Oct 28, 2010 | clinicaltrials |
| NCT00887692 | Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy | completed | N/A | 10 | University Hospital, GhentOTHER | 1 | Oct 19, 2010 | clinicaltrials |
| NCT00735150 | Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk | completed | — | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 11, 2010 | clinicaltrials |
| NCT00002509 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | completed | Phase 1 / Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00367250 | Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer | unknown | Phase 1 | 32 | Medical University of ViennaOTHER | 1 | Sep 28, 2010 | clinicaltrials |
| NCT00082654 | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients | completed | N/A | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT01203267 | Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer | completed | Phase 2 | 108 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT00524849 | Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis | completed | Phase 2 / Phase 3 | 60 | Fudan UniversityOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT01196455 | Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer | unknown | Phase 2 | 39 | Croatian Cooperative Group for Clinical Research in OncologyOTHER | 1 | Sep 8, 2010 | clinicaltrials |
| NCT00170235 | Reducing Arm Morbidity in Pre- and Post-breast Cancer Surgery | completed | N/A | 50 | McGill UniversityOTHER | 1 | Sep 6, 2010 | clinicaltrials |
| NCT01195298 | Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer | unknown | Phase 2 | 88 | South Eastern European Research Oncology GroupOTHER | 1 | Sep 6, 2010 | clinicaltrials |
| NCT00740532 | Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients | completed | — | 11 | Istituto Clinico HumanitasOTHER | 1 | Sep 2, 2010 | clinicaltrials |
| NCT00874146 | Level of HER2-neu Gene Amplification an Response to Trastuzumab | unknown | — | 100 | Istituto Clinico HumanitasOTHER | 1 | Sep 2, 2010 | clinicaltrials |
| NCT01175694 | Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer | unknown | Phase 2 | 200 | University Hospital ErlangenOTHER | 1 | Aug 20, 2010 | clinicaltrials |
| NCT00418236 | Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density | completed | — | 400 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 14 | Aug 19, 2010 | clinicaltrials |
| NCT00705315 | Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer | completed | Phase 1 / Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00193115 | Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer | completed | Phase 2 | 32 | SCRI Development Innovations, LLCOTHER | 0 | Aug 4, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00668616 | Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes | completed | Phase 3 | 1,034 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00191789 | Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer | completed | Phase 2 | 65 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00607295 | Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients | completed | Phase 3 | 98 | Seoul National University HospitalOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT01170143 | Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer(PCH) | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00648102 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer(CDX1307-02) | completed | Phase 1 | 36 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00709462 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | completed | Phase 1 | 48 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00185809 | Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study | completed | — | 25 | Stanford UniversityOTHER | 1 | Jul 20, 2010 | clinicaltrials |
| NCT00255060 | Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer | completed | — | 100 | Stanford UniversityOTHER | 1 | Jul 20, 2010 | clinicaltrials |
| NCT01164748 | Lymphatic Mapping After Previous Breast Surgery(LABS) | completed | — | — | Catharina Ziekenhuis EindhovenOTHER | 1 | Jul 19, 2010 | clinicaltrials |
| NCT00486473 | Multihance Versus Magnevist in Breast MRI(DETECT) | completed | Phase 3 | 130 | Bracco Diagnostics, IncINDUSTRY | 1 | Jul 15, 2010 | clinicaltrials |
| NCT01157026 | A Pilot Clinical Trial With Tocotrienol on Breast Cancer(BC) | completed | N/A | 240 | Malaysia Palm Oil BoardOTHER_GOV | 1 | Jul 5, 2010 | clinicaltrials |
| NCT00196846 | Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) | completed | Phase 2 | 62 | GBG Forschungs GmbHOTHER | 1 | Jun 14, 2010 | clinicaltrials |
| NCT00005822 | SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer | completed | Phase 1 | 21 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006260 | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 36 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00109993 | Campath-1H + FK506 and Methylprednisolone for GVHD | completed | Phase 2 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00847067 | Chronic Post Breast Surgery Pain | terminated | N/A | 40 | Mayo ClinicOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT01142141 | Manual Therapy in Postoperative Breast Cancer | completed | N/A | 136 | University of Campinas, BrazilOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006261 | Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00855998 | Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer | unknown | — | 300 | Hadassah Medical OrganizationOTHER | 1 | Jun 3, 2010 | clinicaltrials |
Data updated 24 days agoSource updated Dec 21, 2010source: clinicaltrials